Using PK Data for Better In Vitro and In Vivo Drug Dosing and Study Design Published 2021-10-19 Download video MP4 360p Recommendations 47:55 Interspecies Drug Dosing using PK Directed Methods 58:50 Animal Scale Up and First-in-Human Studies with Dr. Jerry Collins 53:02 Molecular Imaging and Theranostics of Cancer 24:28 Pharmacokinetics and Pharmacodynamics 1:17:25 GastroPlus® “Workshop from Home” April 17 PBPK PD modeling course with Haiying Zhou 53:48 Human Participant Protections in Clinical Research 03:35 In vitro potency assays for cancer immunotherapy on the Maestro ZHT system 56:13 MDC Connects: Understanding the PK / PD Relationship 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 21:13 Clinical Trials in Adult Acute Lymphoblastic Leukemia 27:12 Dr Sam Salman Pharmacokinetic modelling non compartemental analysis vs population pharmacokinetic 41:38 2. The nature of persons: dualism vs. physicalism 52:51 Pharmacodynamic and Pharmacokinetic Modeling of Data with Dr. Joga Gobburu 27:34 Allometric Scaling in PK PD Modeling 53:56 Webinar - Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic 24:19 Pharmacokinetics | Dosage Regimen 04:30 Esophageal Cancer - Mark Koebrich's Story 1:21:29 Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram 01:34 In vivo vs. in vitro drug development 54:45 Oncology drug delivery in preclinical models -- PK/PD relationships Similar videos 03:18 The benefits of using Pharmacokinetic and Pharmacodynamic modeling 19:56 PBPK to Guide Study Design and Product Development for Generic Dermatological Products 42:52 Role of DMPK in Drug Discovery and Development 36:56 Application Of In Vitro And In Vivo Adme Pk Expl Tox Assays To Support Lead And Candidate Selections 20:46 In Vitro Studies for Alternative BE Approaches to Comparative Clinical Endpoint BE Studies 40:57 Precision Dosing Using PBPK Modeling 03:35 free drug hypothesis, dosing predictions, & PK/PD 45:13 Design Intricacies and Decision Making Strategy for Drug Drug Interaction Studies 08:20 Korsmeyer Peppas Model Fitting of Drug Release Data | Calculation of Parameters 22:37 Komabiotech Webinar - In Vivo Pharmacology and PK Services - Pharmacology Discovery Services (PDS) 34:30 Kinetics of Target Binding: Impact on Drug Activity from Bench to Bedside 59:39 Physiologically Based Pharmacokinetic Modelling for First‑In‑Human Predictions 1:02:26 In Vitro Assessment of ADME Properties of Lead Compounds 53:56 Webinar: In vivo pharmacokinetic experiments in preclinical drug development 1:16:01 In Vitro and In Vivo BE Approaches: Challenges and Opportunities – Session 3B 36:24 Physiologically-based Pharmacokinetics Modeling: An Approach for Designing Better Clinical Trials More results